Daiwa Securities Group
PRVL

Daiwa Securities Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Daiwa Securities Group’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-64
Closed -$1K – 1305
2020
Q4 		$1K Sell
64
-128
-67% -$1.62K ﹤0.01% 1251
2020
Q3 		$2K Hold
192
– – ﹤0.01% 1154
2020
Q2 		$2K Hold
192
– – ﹤0.01% 1175
2020
Q1 		$2K Hold
192
– – ﹤0.01% 1177
2019
Q4 		$3K Buy
+192
New +$2.45K ﹤0.01% 1153

Daiwa Securities Group's PRVL Position: Q1 2021 in Review

Daiwa Securities Group sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 64 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in PRVL in Q4 2019 and held it in 5 quarters. The position peaked at $3K in Q4 2019. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

  • Daiwa Securities Group reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 64 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $1K.
  • Daiwa Securities Group first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Daiwa Securities Group's Prevail Therapeutics Inc. Common Stock position peaked at $3K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.